Ruxolitinib phosphateMeSH concept

https://ansm.sante.fr/tableau-acces-derogatoire/jakavi-5-mg-comprime
2025
false
false
false
France
French
insurance, health, reimbursement
ruxolitinib phosphate
ruxolitinib
administration, oral
graft vs host disease
Steroid Refractory Graft Versus Host Disease
acute disease
chronic disease
pharmaceutical solutions
child
guidelines for drug use
summary of product characteristics
package leaflet
tablets

---
https://www.ema.europa.eu/en/medicines/human/EPAR/opzelura
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
ruxolitinib
ruxolitinib
ruxolitinib
vitiligo
adult
adolescent
administration, cutaneous
ointments
Janus Kinase Inhibitors
Janus Kinase Inhibitors
JAK1 Inhibitor
JAK2 Inhibitor
janus kinase 1
janus kinase 2
ruxolitinib phosphate
ruxolitinib phosphate
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---